Pécs, Hungary

Kálmán Hideg


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kálmán Hideg - Innovator in Pharmaceutical Chemistry

Introduction

Kálmán Hideg is a notable inventor hailing from Pécs, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent focused on quinazolinone derivatives. His work aims to enhance therapeutic options for various illnesses, particularly those related to DNA repair mechanisms.

Latest Patents

Kálmán Hideg holds a patent titled "Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having PARP enzyme inhibitory effect." This invention revolves around the development of quinazoline derivatives and their pharmaceutically acceptable salts, which are instrumental in inhibiting poly(ADP-ribose) polymerase (PARP), a critical enzyme involved in DNA repair. The general formula (I) of his patent outlines that R may represent hydrogen or other specified groups, ultimately paving the way for these compounds to be utilized in pharmaceutical formulations that can prevent or treat conditions where PARP inhibition is beneficial.

Career Highlights

Kálmán Hideg is affiliated with the University of Pécs, a reputed institution where he applies his expertise in research and innovation. His singular patent showcases his commitment to advancing medical science and enhancing therapeutic strategies for treating diseases linked to DNA repair deficiencies.

Collaborations

Throughout his career, Kálmán has collaborated with fellow researchers Balázs Sümegi and Tamás Kálai. Their combined efforts significantly contribute to the field of pharmaceutical research, fostering an environment of innovative thinking and problem-solving in the context of drug development.

Conclusion

Kálmán Hideg is a distinguished inventor whose work on quinazolinone derivatives holds promise for transformative impacts in the field of pharmaceuticals. His dedication, along with collaborative relationships with colleagues, continues to inspire advancements in medicine aimed at improving patient outcomes and addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…